A good week isn't zero migraines. It's the ones that ended sooner.

The Sunday-night scorecard problem

It's Sunday night and the week's log is closed. Three attacks this week. Two of them dragged a full day of brain fog behind them. And the reflex, the one every chronic migraineur knows, is to read that as failure.

Here's what that scorecard leaves out. Last month, the same seven days would have held five attacks, maybe six, each with a postdrome that ran a day and a half. Three is not a bad week. Three is the shape of something working. But the number staring back from the calendar doesn't say that, because the calendar was built to count attacks, not to measure the distance you've traveled from where you were.

Grade on the delta, not the zero

Call it grading on the delta. The useful measure of a week isn't its distance from zero attacks. It's its distance from your own recent baseline.

Two attacks down from seven is a result. A postdrome that clears in eighteen hours instead of thirty-six is a result. Photophobia that lifts by lunch instead of lingering until the next morning is a result. None of those show up as a green checkmark on an app that only knows how to celebrate an empty month. So the reader who is genuinely improving gets told, week after week, that they are still losing. That is a measurement failure, not a treatment failure.

You are not failing at treatment. You are measuring it against the wrong number.

Why 'zero attacks' is the wrong target

Chronic migraine is a clinical category, not a temporary rough patch. Under the international diagnostic criteria, it means headache on fifteen or more days a month, with migraine features on at least eight of them, sustained over months. For that population, a treatment that eliminated every attack would be extraordinary, and it is not what most people on a preventive are told to expect.

So when an app frames the goal as an empty calendar, it imports a target borrowed from acute, episodic patients and hands it to people whose reality it does not fit. The reader internalizes it anyway. And a preventive that took someone from twelve attack-days to six can start to feel like it isn't doing anything, because the tool never learned to show the drop.

What the after-phase actually tells you

The headache is the part that gets logged. The postdrome is the part that gets skipped, and it is often where improvement shows up first.

The after-phase carries fatigue, residual photophobia, neck stiffness, difficulty concentrating, and a flattened mood that can outlast the pain by a day or more. Diary research on the migraine postdrome consistently finds that most patients report at least one non-headache symptom in the hours after the pain resolves. That phase is measurable. Its length moves. And because a preventive or an acute medication can shorten the postdrome before it meaningfully cuts attack frequency, the after-phase is frequently the earliest honest signal that something is changing. An attack count alone will miss it entirely.

One week, read two ways

Take a real-shaped week. Wednesday, a full attack, treated late, with a postdrome that runs into Friday morning. Saturday, a second attack, treated inside the hour, resolved by evening with only a few hours of fog.

Read as a scorecard: two attacks, another failed week. Read on the delta: the Saturday attack was caught early and cost a fraction of what Wednesday's did, which is exactly the pattern you want a treatment plan to produce. The difference between those two readings isn't optimism. It's what you chose to record. If your log holds treatment timing and postdrome length next to the attack, the week tells a story about what's working. If it holds only a tally, the week just tells you that you're still sick, which you already knew.

What changes when 'better' is the target

Reframe the target and the appointment changes too. Walking into a neurologist's office able to say 'my attacks dropped from roughly seven a fortnight to four, and my postdromes are clearing about a day faster' is a different conversation than 'I still get migraines.' The first gives a clinician a trend to titrate against. The second gives them nothing.

It changes the internal story as well. A person who can see the drop stops reading every attack as proof that nothing helps, which is the belief that most quietly erodes adherence to a preventive. Documenting better, honestly, is how you keep taking the thing that is slowly making the weeks less bad.

A tracker for proving the delta

This is the standard we built Postdrome around. The timeline doesn't end when the pain does, because for most of the people we built it for, the pain ending is not when the day gets its life back. The after-phase gets its own record: how long the fog held, when the photophobia lifted, whether the mood came back before or after the light sensitivity.

The point isn't a prettier chart. The point is that when your attacks are getting shorter or fewer, you can see it, and so can your neurologist. No scoring, no green-for-a-clean-month gamification, no language that treats a migraine as a personal shortcoming. Lifetime pricing, on-device, and your data exports whenever you want to take it to an appointment. A tool for documenting better, not a referee handing out a grade for perfect.

What we're watching next

The open question is which after-phase signal moves first. Anecdotally, in community threads on r/migraine and r/cgrpMigraine, people starting a new preventive often describe the postdrome easing before the attack count does. Whether that ordering holds across a large, well-logged population is worth documenting properly, and it's the kind of pattern that only surfaces when the after-phase is tracked as carefully as the headache. That's the data we most want to see.